Efficacy and safety of concurrent chemoradiotherapy with paclitaxel-based or S-1 regimens in treating elderly patients with esophageal squamous cell carcinoma: A multi-center propensity-score matched study
Our findings suggest that paclitaxel-based CCRT was well tolerated in elderly patients with ESCC and provided significant survival benefits over S-1 regimen.
Authors
- Yiyu Guo (ORCID: https://orcid.org/0000-0001-8706-8435)
- Zhi Zhang (ORCID: https://orcid.org/0000-0001-6256-9516)
- Guoren Zhou (ORCID: https://orcid.org/0000-0001-5344-8480)
- Xuefeng Zhou (ORCID: https://orcid.org/0000-0001-9601-4869)
- Hui Li (ORCID: https://orcid.org/0000-0002-7516-7126)
- Daguang Wu
- Jinjun Ye (ORCID: https://orcid.org/0000-0001-5234-4882)
- Haifeng Shi
- Tian Wang
- Huiguo Shan
Institutions
- Jiangsu University (CN)
- Xuzhou Cancer Hospital (CN)
- Suzhou Municipal Hospital (CN)
- Yancheng Third People's Hospital (CN)
- Jiangsu Cancer Hospital (CN)
- Yancheng Second People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1016/j.tranon.2024.102123
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Bethune Charitable Foundation